In this single-centre, randomized, double-blind, placebo-controlled, phase II trial, a 72-h infusion of IgM-enriched immunoglobulins (Pentaglobin) in patients with sepsis or septic shock was associated with an increase in sublingual microvascular perfusion. The gene discussed is CD40LG; the disease is Sepsis.